ESMO-Magnitude of Clinical Benefit Scale
A validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
A validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
A framework to rank genomic alterations as targets for cancer precision medicine.
ESMO-GROW is the first reporting guidance specifically developed for oncology real-world evidence studies.
The ESMO Checklists collection, developed by the Practising Oncologists Working Group, provide self-assessment checklists for oncologists at the point of care.
ESMO has developed a set of organ-specific tools designed to assist oncologists in their daily practice
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.